Mammalian target of rapamycin (mTOR) is a crucial regulator of cell growth and metabolism and has been implicated in aging and many diseases, including cancer, diabetes and neurological diseases (Zoncu et al. 2011; Dazert and Hall 2011). This evidence concerns the gene MTOR and diabetes mellitus.